Physician profile
Michael Alan Balk
NPI 1205820024
$7,711.42
in general payments reported to CMS, 2019-2025
9 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2022: $137 · 2023: $92.00 · 2024: $5,451 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,950 · Travel and Lodging: $501 · Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,950.00 |
| Travel and Lodging | $500.95 |
| Food and Beverage | $194.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $5,450.95 | 2024 | (2858) General Consulting |
| Intuitive Surgical, INC. | $1,778.14 | 2019 | |
| Akcea Therapeutics, INC. | $119.88 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.13 | 2022 | |
| Heartflow, INC. | $102.70 | 2025 | |
| Kestra Medical Technology Services, INC. | $92.00 | 2023 | Assure Wcd |
| Cardiva Medical, INC. | $18.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.02 | 2022 | |
| Merck Sharp & Dohme LLC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Balk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.